The ‘landmark’ decision invalidates Regeneron’s patent claims covering its genetically modified mice

The trial will see around 300 people given the vaccine plus a booster shot up to four weeks […]

The move provides the opportunity to conduct essential post-marketing surveillance

The triple therapy is currently under review for COPD in both the EU and US

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT

Bayer inks largest settlement in pharma history with $10B Roundup deal kblankenship Wed, 06/24/2020 – 13:49

Regeneron vows to fight DOJ lawsuit alleging charity donations were Eylea kickbacks esagonowsky Wed, 06/24/2020 – 16:23